Prevention of Delirium After Bone Marrow Transplantation

Stopped early · Not applicable · Has a placebo group

Conditions studied: Delirium

In brief

The purpose of this study is to find out if using bright light sessions during bone marrow transplant can prevent people from developing confusion also known as delirium.

Key facts

Study ID

NCT01700816

Run by

Massachusetts General Hospital

People needed

40

Starts

2012-10-01

Expected to finish

2013-10-01

Last updated by the study team

2017-06-28

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 or older
• Male or female
• Patients scheduled to undergo HSCT
• English speaking

You may not qualify if…

• Previous history of bipolar affective disorder
• On-going delirium
• History of substance abuse/dependence within 6 months prior to HSCT
• History of invasive melanoma. Patients with a history of basal cell carcinoma, melanoma in situ, or squamous cell carcinoma are permitted to enroll if the lesion(s) have been excised with negative margins
• History of medical/dermatological conditions that make skin especially sensitive to light,such as systemic lupus erythematosus (SLE) and/or porphyria
• Eye condition that makes eyes vulnerable to light damage
• Concomitant use of medications that increase sensitivity to sunlight, such as the herbal supplement St. John's Wort
• Established primary insomnia

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.